Synthesis, leishmanicidal, trypanocidal and cytotoxic activities of quinoline-chalcone and quinoline-chromone hybrids
- 232 Downloads
We report herein the synthesis and biological activities (cytotoxicity, leishmanicidal and trypanocidal) of six quinoline-chalcone and five quinoline-chromone hybrids. The synthesized compounds were evaluated against amastigotes forms of Leishmania (V) panamensis, which is the most prevalent Leishmania species in Colombia and Trypanosoma cruzi, which is the major pathogenic species to humans. Cytotoxicity was evaluated against human U-937 macrophages. Compounds 8–12, 20, 23 and 24 showed activity against Leishmania (V) panamensis, while compounds 9, 10, 12, 20 and 23 had activity against Trypanosoma cruzi with EC50 values lower than 18 mg mL−1. 20 was the most active compound for both Leishmania (V) panamensis and Trypanosoma cruzi with EC50 of 6.11 ± 0.26 μg mL−1 (16.91 μM) and 4.09 ± 0.24 (11.32 μM), respectively. All hybrids compounds showed better activity than the anti-leishmanial drug meglumine antimoniate. Compounds 20 and 23 showed higher activity than benznidazole, the current anti-trypanosomal drug. Although these compounds showed toxicity for mammalian U-937 cells,they still have the potential to be considered as candidates to antileishmanial or trypanocydal drug development.
KeywordsLeishmaniasis Chagas disease Antiprotozoal activity Quinoline Hybrids molecules
The authors thank Universidad de Antioquia (grant CODI IN656CE and CIDEPRO) for financial support.
Conflict of interest
The authors declare that they have no competing interests.
- Baloch N, Alkahraman Y, Zaidi M, Madkour H (2012) Evaluation of 6, 8-dichloro-2-methyl-4H-chromen-4-one derivatives as Antileishmanial agents. Glob J Sci Front Res Chem 12:1–7Google Scholar
- Chatelain E, Ioset JR (2011) Drug discovery and development for neglected diseases: the DNDi model. Drug Des Devel Ther 16:175–181Google Scholar
- Finney JD (1978) Probit analysis: statistical treatment of the sigmoid response curve, 3rd ed.. Cambridge University Press, Cambridge, p 550Google Scholar
- Insuasty B, Ramirez J, Becerra D, Echeverry C, Quiroga J, Abonia R, Robledo SM, Velez ID, Upegui Y, Muñoz JA, Ospina V, Nogueras M, Cobo J (2015) An efficient synthesis of a new caffeine-based chalcones, pyrazolines and pyrazolo[3-4-b][1-4]diazepines as potential antimalarial, antitrypanosomal and antileishmanial agents. Eur J Chem Med 93:401–413CrossRefGoogle Scholar
- Nakayama H, Loiseau PM, Bories C, De Ortiz ST, Schinini A, Serna E, Rojas de Arias A, Fakhfakh MA, Franck X, Figadère B, Hocquemiller R, Fournet A (2005) Efficacy of orally administered 2- substituted quinolines in experimental murine cutaneous and visceral leishmaniases. Antimicrob Agents Chemother 49:4950–4956CrossRefPubMedPubMedCentralGoogle Scholar
- Taylor VM, Cedeño DL, Muñoz DL, Jones MA, Lash TD, Young AM, Constantino MH, Esposito N, Vélez ID, Robledo SM (2011) In vitro and in vivo studies of the utility of dimethyl and diethyl carbaporphyrin ketals in treatment of cutaneous leishmaniasis. Antimicrob Agents Chemother 55:4755–4764CrossRefPubMedPubMedCentralGoogle Scholar
- World Health Organization (2013) Why are some tropical diseases called ‘neglected’ http://www.who.int/features/qa/58/en/. Accessed 4 Dec 2013